CLDX Operating Cash Flow (Statement)

Celldex Therapeutics Inc · Operating Cash Flow (Statement)

CLDX logo

CLDX Operating Cash Flow (Statement)

Latest reported-$235.57M
CLDX TTM Cash from Operations (-$3.40M → -$235.57M)
High-resolution chart · PNG

CLDX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Celldex Therapeutics Inc Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
-235,566,000
-222,161,000
-210,945,000
-179,481,000
-186,190,000
-171,512,000
-157,778,000
-157,835,000
-121,491,000
-119,360,000
-107,291,000
-96,520,000
-112,719,000
-107,767,000
-103,732,000
-96,493,000
-77,673,000
-67,359,000
-60,909,000
-51,597,000
-47,086,000
-46,378,000
-40,404,000
-46,193,000
-45,472,000
-45,292,000
-46,415,000
-50,845,000
-54,093,000
-60,446,000
-75,235,000
-79,326,000
-89,299,000
-92,691,000
-99,931,000
-100,759,000
-100,353,000
-113,396,000
-113,036,000
-106,432,000
-110,268,000
-101,200,000
-98,887,000
-107,356,000
-106,157,000
-102,251,000
-101,537,000
-94,280,000
-85,142,000
-82,344,000
-67,669,000
-66,038,000
-59,528,000
-53,429,000
-49,782,000
-45,826,000
-42,941,000
-40,347,000
-35,658,000
-32,303,000
-31,986,000
-32,296,000
-30,372,000
-35,200,000
-32,962,000
-31,259,028
-29,869,000
-17,731,175
-21,205,904
17,037,532
18,280,766
12,952,700
17,382,836
-17,340,357
-19,302,986
-17,242,950
-16,557,682
-16,355,510
27,000,319
31,047,514
30,656,790
35,115,024
-6,016,630
-11,626,220
-10,383,871
-12,236,992
-10,347,900
-10,095,800
-9,805,000
-10,818,000
-11,739,400
-9,383,000
-11,822,600
-14,327,800
-16,659,400
-21,198,300
-21,789,700
-20,965,100
-20,825,500
-15,646,700
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.